APOE and hyperlipidemia: In connection with this hypothesis, we recently identified apolipoprotein E (apoE) as a soluble receptor for pyrP and observed accelerated lysine N-pyrrolation associated with the accumulation of antibodies (Abs) against pyrP and DNA in apoE-deficient (apoE−/−) hyperlipidemia mice (Fig. 1B) (15).